inositol has been researched along with Hyperlipemia in 21 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "70 patients with hyperlipemias of various types were treated perorally with 350 mg Mg-chlorophenoxyisobutyrate, and 250 mg of mesoinositol-hexanicotinate (Atroplex) three times daily." | 3.65 | [Clinical study with a new antihyperlipemic combination]. ( Pistautz, H, 1977) |
| "Postprandial hyperglycemia and hyperlipidemia are considered risk factors for cardiovascular disease." | 2.72 | An alpha-glucosidase inhibitor, voglibose, reduces oxidative stress markers and soluble intercellular adhesion molecule 1 in obese type 2 diabetic patients. ( Aizawa-Abe, M; Kuzuya, H; Ogawa, Y; Satoh, N; Shimatsu, A; Suganami, T; Yamada, K, 2006) |
| "Clofibrate and m-Inositolnicotinate in a daily dosage of 1,5 g Clofibrate and 1,2 g m-Inositolnicotinate during long term treatment effected a good triglyceride fall in all three lipoprotein fractions, especially in VLDL." | 2.64 | [Combination or monotherapy of hyperlipoproteinemia typus IIb, IV, V with clofibrate and m-inositolnicotinate or clofibrinic acid (author's transl)]. ( Schwartzkopff, W; Zschiedrich, M, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bañuls, C | 1 |
| Rovira-Llopis, S | 1 |
| Falcón, R | 1 |
| Veses, S | 1 |
| Monzó, N | 1 |
| Víctor, VM | 1 |
| Rocha, M | 1 |
| Hernández-Mijares, A | 1 |
| Antony, PJ | 1 |
| Gandhi, GR | 1 |
| Stalin, A | 1 |
| Balakrishna, K | 1 |
| Toppo, E | 1 |
| Sivasankaran, K | 1 |
| Ignacimuthu, S | 1 |
| Al-Dhabi, NA | 1 |
| Maeba, R | 1 |
| Hara, H | 1 |
| Ishikawa, H | 1 |
| Hayashi, S | 1 |
| Yoshimura, N | 1 |
| Kusano, J | 1 |
| Takeoka, Y | 1 |
| Yasuda, D | 1 |
| Okazaki, T | 1 |
| Kinoshita, M | 1 |
| Teramoto, T | 1 |
| Odaka, H | 1 |
| KNUECHEL, F | 1 |
| Nath, MC | 1 |
| Saikia, A | 1 |
| Dib, JG | 1 |
| Dedeyan, S | 1 |
| Satoh, N | 1 |
| Shimatsu, A | 1 |
| Yamada, K | 1 |
| Aizawa-Abe, M | 1 |
| Suganami, T | 1 |
| Kuzuya, H | 1 |
| Ogawa, Y | 1 |
| Jariwalla, RJ | 1 |
| Lee, P | 1 |
| Breckenridge, WC | 1 |
| Schwartzkopff, W | 2 |
| Zschiedrich, M | 2 |
| Fischer, M | 1 |
| Falkensammer, C | 1 |
| Pistautz, H | 1 |
| Ide, A | 1 |
| Arteaga, A | 1 |
| Maiz, A | 1 |
| Ortiz, CL | 1 |
| Acosta, AM | 1 |
| Fernandez, M | 1 |
| Schäfer, B | 1 |
| Kluthe, R | 1 |
| Wilke, H | 1 |
| Frahm, H | 1 |
| Rahlfs, VW | 1 |
| Fenster, R | 1 |
| Beckmann, R | 1 |
| Petith, M | 1 |
| Neuman, M | 1 |
| Cachin, M | 1 |
| Galian, P | 1 |
| Charbonnier, A | 1 |
| Pergola, F | 1 |
3 reviews available for inositol and Hyperlipemia
| Article | Year |
|---|---|
[alpha-Glucosidase inhibitor, its structure and mechanism of antidiabetic action].
Topics: Acarbose; Animals; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Hum | 2002 |
Rice-bran products: phytonutrients with potential applications in preventive and clinical medicine.
Topics: Animals; Anticholesteremic Agents; Coumaric Acids; Dietary Fiber; Fatty Liver; Free Radical Scavenge | 2001 |
[Inosite: recent experimental and clinical findigs. Review of the literature and therapeutic experience].
Topics: Animals; Bacteria; Cattle; Central Nervous System; Dogs; Fatty Liver; Female; Humans; Hyperlipidemia | 1970 |
8 trials available for inositol and Hyperlipemia
| Article | Year |
|---|---|
Chronic consumption of an inositol-enriched carob extract improves postprandial glycaemia and insulin sensitivity in healthy subjects: A randomized controlled trial.
Topics: Adult; Blood Glucose; Dietary Supplements; Double-Blind Method; Fabaceae; Female; Fruit; Humans; Hyp | 2016 |
Myo-inositol treatment increases serum plasmalogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndrome.
Topics: Adult; Blood Glucose; Blood Pressure; Body Mass Index; Female; Humans; Hyperlipidemias; Inositol; Li | 2008 |
An alpha-glucosidase inhibitor, voglibose, reduces oxidative stress markers and soluble intercellular adhesion molecule 1 in obese type 2 diabetic patients.
Topics: Adult; Biomarkers; Diabetes Mellitus, Type 2; Female; Glycoside Hydrolase Inhibitors; Humans; Hyperg | 2006 |
[Combination or monotherapy of hyperlipoproteinemia typus IIb, IV, V with clofibrate and m-inositolnicotinate or clofibrinic acid (author's transl)].
Topics: Cholestanol; Chylomicrons; Clinical Trials as Topic; Clofibrate; Drug Evaluation; Drug Therapy, Comb | 1978 |
[New drug combination for medical management of hyperlipemia: clinical study].
Topics: Aged; Blood Glucose; Body Weight; Cholesterol; Clinical Trials as Topic; Clofibrate; Clofibric Acid; | 1977 |
[The effect of a lipid-reducing clofibrate-inositolnicotinate combination compared to clofibrate. A double-blind study].
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Drug Combinations; Female; Humans; Hyperlipidemia | 1975 |
[Treatment of hyperlipoproteinaemia types IIa, IIb, IV and V with a combination of clofibrate and inositol nicotinate (author's transl)].
Topics: Cholesterol; Clofibrate; Female; Humans; Hyperlipidemias; Inositol; Male; Nicotinic Acids; Triglycer | 1976 |
[The management of hyperlipoproteinemia with Liproreduct].
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Drug Combinations; Female; Humans; Hyperlipidemia | 1974 |
10 other studies available for inositol and Hyperlipemia
| Article | Year |
|---|---|
Myoinositol ameliorates high-fat diet and streptozotocin-induced diabetes in rats through promoting insulin receptor signaling.
Topics: Administration, Oral; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diet, Hi | 2017 |
[Effect of Lipokapsul on the serum lipids in arteriosclerosis (with reference to different diet forms)].
Topics: Arteriosclerosis; Coronary Disease; Diet; Diet Therapy; Fatty Acids; Fatty Acids, Essential; Humans; | 1962 |
Effects of essential fatty acids, inositol, vitamin B12 and hydrolyzed glucose-cyclo-acetoacetate on blood coagulation factors in rabbits exhibiting hyperlipemia induced by feeding saturated fat.
Topics: Acetoacetates; Animals; Blood Coagulation; Blood Coagulation Factors; Diet; Fatty Acids; Fatty Acids | 1959 |
Purported benefits of inositol niacinate.
Topics: Administration, Oral; Anticholesteremic Agents; Humans; Hyperlipidemias; Inositol; Lipoproteins, VLD | 2004 |
The carbohydrate composition of human apo low density lipoprotein from normal and type II hyperlipoproteinemic subjects.
Topics: Adult; Apoproteins; Cholesterol; Chromatography, Gas; Glucosamine; Humans; Hyperlipidemias; Inositol | 1976 |
[The problem of type changes in hyperlipoproteinemia (type IIb, IV, V) under clofibrate and m-inositol nicotinate therapy].
Topics: Clofibrate; Drug Combinations; Humans; Hyperlipidemias; Inositol; Lipoproteins, HDL; Lipoproteins, L | 1976 |
[Clinical study with a new antihyperlipemic combination].
Topics: Adult; Aged; Blood Pressure; Cholesterol; Clofibrate; Drug Combinations; Female; Hemostasis; Humans; | 1977 |
[The effect of messoinositol hexanicotinate on the treatment of primary hyperlipidemia (author's transl)].
Topics: Adult; Aged; Drug Evaluation; Female; Humans; Hyperlipidemias; Inositol; Male; Middle Aged | 1976 |
[Letter: Clofibrate and clofibrate-inositolnicotinate].
Topics: Clofibrate; Drug Combinations; Hyperlipidemias; Inositol; Nicotinic Acids | 1976 |
[Treatment of hyperlipemia and steatosis by high doses of meso-insitol hexanicotinate].
Topics: Adult; Fatty Liver; Humans; Hyperlipidemias; Inositol; Middle Aged; Nicotinic Acids | 1968 |